Goldman Sachs’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.83B | Buy |
6,340,865
+390,971
| +7% | +$396M | 0.67% | 15 |
|
|
2025
Q4 | $6.39B | Sell |
5,949,894
-704,912
| -11% | -$674M | 0.78% | 14 |
|
|
2025
Q3 | $5.08B | Buy |
6,654,806
+1,153,495
| +21% | +$858M | 0.62% | 21 |
|
|
2025
Q2 | $4.29B | Buy |
5,501,311
+168,018
| +3% | +$131M | 0.58% | 24 |
|
|
2025
Q1 | $4.4B | Buy |
5,333,293
+369,603
| +7% | +$308M | 0.71% | 18 |
|
|
2024
Q4 | $3.83B | Buy |
4,963,690
+313,240
| +7% | +$259M | 0.6% | 21 |
|
|
2024
Q3 | $4.12B | Sell |
4,650,450
-277,490
| -6% | -$249M | 0.66% | 18 |
|
|
2024
Q2 | $4.46B | Buy |
4,927,940
+408,381
| +9% | +$327M | 0.75% | 16 |
|
|
2024
Q1 | $3.52B | Sell |
4,519,559
-160,374
| -3% | -$114M | 0.62% | 17 |
|
|
2023
Q4 | $2.73B | Sell |
4,679,933
-159,123
| -3% | -$92.9M | 0.5% | 25 |
|
|
2023
Q3 | $2.6B | Sell |
4,839,056
-716
| -0% | -$369K | 0.55% | 24 |
|
|
2023
Q2 | $2.27B | Sell |
4,839,772
-845,234
| -15% | -$354M | 0.49% | 30 |
|
|
2023
Q1 | $1.95B | Buy |
5,685,006
+847,845
| +18% | +$286M | 0.45% | 29 |
|
|
2022
Q4 | $1.77B | Buy |
4,837,161
+70,963
| +1% | +$25.2M | 0.43% | 28 |
|
|
2022
Q3 | $1.54B | Buy |
4,766,198
+91,654
| +2% | +$29M | 0.39% | 32 |
|
|
2022
Q2 | $1.52B | Buy |
4,674,544
+180,850
| +4% | +$54.3M | 0.38% | 36 |
|
|
2022
Q1 | $1.29B | Buy |
4,493,694
+208,962
| +5% | +$53.8M | 0.27% | 47 |
|
|
2021
Q4 | $1.18B | Sell |
4,284,732
-471,398
| -10% | -$120M | 0.24% | 58 |
|
|
2021
Q3 | $1.1B | Buy |
4,756,130
+460,649
| +11% | +$114M | 0.23% | 53 |
|
|
2021
Q2 | $986M | Buy |
4,295,481
+7,172
| +0.2% | +$1.44M | 0.22% | 63 |
|
|
2021
Q1 | $801M | Buy |
4,288,309
+247,977
| +6% | +$48.5M | 0.2% | 73 |
|
|
2020
Q4 | $682M | Buy |
4,040,332
+463,355
| +13% | +$69.2M | 0.18% | 96 |
|
|
2020
Q3 | $529M | Sell |
3,576,977
-721,527
| -17% | -$112M | 0.15% | 119 |
|
|
2020
Q2 | $706M | Sell |
4,298,504
-514,552
| -11% | -$79M | 0.21% | 75 |
|
|
2020
Q1 | $668M | Sell |
4,813,056
-838,299
| -15% | -$115M | 0.24% | 80 |
|
|
2019
Q4 | $743M | Buy |
5,651,355
+503,864
| +10% | +$58.4M | 0.19% | 93 |
|
|
2019
Q3 | $576M | Sell |
5,147,491
-1,358,855
| -21% | -$151M | 0.17% | 104 |
|
|
2019
Q2 | $721M | Buy |
6,506,346
+936,531
| +17% | +$110M | 0.21% | 78 |
|
|
2019
Q1 | $723M | Sell |
5,569,815
-1,355,606
| -20% | -$165M | 0.22% | 79 |
|
|
2018
Q4 | $801M | Sell |
6,925,421
-526,608
| -7% | -$58.8M | 0.26% | 61 |
|
|
2018
Q3 | $800M | Buy |
7,452,029
+24,631
| +0.3% | +$2.46M | 0.21% | 78 |
|
|
2018
Q2 | $634M | Sell |
7,427,398
-1,666,910
| -18% | -$137M | 0.17% | 95 |
|
|
2018
Q1 | $704M | Buy |
9,094,308
+386,842
| +4% | +$31.1M | 0.18% | 95 |
|
|
2017
Q4 | $735M | Buy |
8,707,466
+1,023,196
| +13% | +$87.1M | 0.18% | 93 |
|
|
2017
Q3 | $657M | Sell |
7,684,270
-363,888
| -5% | -$29.8M | 0.16% | 97 |
|
|
2017
Q2 | $662M | Buy |
8,048,158
+632,972
| +9% | +$51.6M | 0.17% | 94 |
|
|
2017
Q1 | $624M | Sell |
7,415,186
-170,330
| -2% | -$13.6M | 0.17% | 98 |
|
|
2016
Q4 | $558M | Buy |
7,585,516
+1,513,504
| +25% | +$113M | 0.16% | 101 |
|
|
2016
Q3 | $487M | Sell |
6,072,012
-858,417
| -12% | -$68.7M | 0.15% | 103 |
|
|
2016
Q2 | $546M | Buy |
6,930,429
+3,969,317
| +134% | +$299M | 0.18% | 83 |
|
|
2016
Q1 | $213M | Sell |
2,961,112
-702,879
| -19% | -$53.2M | 0.07% | 315 |
|
|
2015
Q4 | $309M | Buy |
3,663,991
+745,676
| +26% | +$61.9M | 0.1% | 214 |
|
|
2015
Q3 | $244M | Sell |
2,918,315
-1,119,227
| -28% | -$94.5M | 0.08% | 245 |
|
|
2015
Q2 | $337M | Sell |
4,037,542
-950,060
| -19% | -$72.4M | 0.1% | 193 |
|
|
2015
Q1 | $362M | Sell |
4,987,602
-100,144
| -2% | -$7.13M | 0.12% | 173 |
|
|
2014
Q4 | $351M | Buy |
5,087,746
+154,899
| +3% | +$10.5M | 0.11% | 179 |
|
|
2014
Q3 | $320M | Sell |
4,932,847
-898,729
| -15% | -$56.9M | 0.1% | 194 |
|
|
2014
Q2 | $363M | Sell |
5,831,576
-1,385,389
| -19% | -$82.7M | 0.11% | 171 |
|
|
2014
Q1 | $425M | Buy |
7,216,965
+321,868
| +5% | +$18M | 0.14% | 134 |
|
|
2013
Q4 | $352M | Buy |
6,895,097
+689,846
| +11% | +$34.5M | 0.12% | 171 |
|
|
2013
Q3 | $312M | Buy |
6,205,251
+359,084
| +6% | +$18.8M | 0.12% | 169 |
|
|
2013
Q2 | $287M | Buy |
+5,846,167
| New | +$318M | 0.11% | 174 |
|
Other funds holding LLY
VCM
VPM
Goldman Sachs's LLY Position: Q1 2026 in Review
Goldman Sachs increased its Eli Lilly (LLY) stake by 6.6% in Q1 2026, buying an estimated $396M and bringing the position to 6,340,865 shares worth $5.83B. The position accounts for 0.67% of the portfolio, ranked #15.
Goldman Sachs first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.39B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Goldman Sachs held 6,340,865 shares of Eli Lilly worth $5.83B as of Q1 2026.
- Goldman Sachs bought 390,971 Eli Lilly shares in Q1 2026, an estimated $396M.
- Eli Lilly made up 0.67% of Goldman Sachs's portfolio in Q1 2026, its #15 holding.
- Goldman Sachs first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Eli Lilly position peaked at $6.39B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.